uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view
- PMID: 17334498
uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view
Abstract
The urokinase-type plasminogen activator (uPA), its inhibitor PAI-1 and its cellular receptor (uPAR), play a pivotal role in pericellular proteolysis. In addition, through their interactions with extracellular matrix proteins as well as with transmembrane receptors and other links to the intracellular signaling machinery, they modulate cell migration, cell-matrix interactions and signaling pathways. A large body of experimental evidence from in-vitro and in-vivo data as well as from the clinics indicates an important role of the uPA-uPAR-PAI-1 systems in cancer. In addition to their role in tumor cell biology, the uPA-uPAR-PAI-1 systems are also important for vascular biology by modulating angiogenesis and by altering migration of smooth muscle cells and fibrin deposition in atherosclerosis and restenosis. This review will focus on the general mechanism of uPAR/uPA/PAI-1 interactions and signaling and the possible relevance of this system in vascular biology.
Similar articles
-
Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer.Gynecol Oncol. 2001 Jan;80(1):48-55. doi: 10.1006/gyno.2000.6015. Gynecol Oncol. 2001. PMID: 11136569
-
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398. Stem Cells. 1997. PMID: 9402652 Review.
-
Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.J Am Soc Nephrol. 2004 Aug;15(8):2090-102. doi: 10.1097/01.ASN.0000135057.41526.2C. J Am Soc Nephrol. 2004. PMID: 15284295
-
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.Int J Oncol. 2009 Jan;34(1):15-23. Int J Oncol. 2009. PMID: 19082473
-
Urokinase-type plasminogen activator system and breast cancer (Review).Oncol Rep. 2005 Jul;14(1):105-12. Oncol Rep. 2005. PMID: 15944776 Review.
Cited by
-
In vitro and in vivo anti-angiogenic activity of girinimbine isolated from Murraya koenigii.Drug Des Devel Ther. 2015 Mar 3;9:1281-92. doi: 10.2147/DDDT.S71557. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25767375 Free PMC article.
-
PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice.Thorax. 2011 Sep;66(9):788-96. doi: 10.1136/thx.2010.155788. Epub 2011 Jul 18. Thorax. 2011. PMID: 21768189 Free PMC article.
-
Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.Leukemia. 2011 Aug;25(8):1286-1296. doi: 10.1038/leu.2011.62. Epub 2011 Apr 15. Leukemia. 2011. PMID: 21494253 Free PMC article.
-
siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats.Acta Pharmacol Sin. 2012 Jul;33(7):897-908. doi: 10.1038/aps.2012.39. Epub 2012 Jun 4. Acta Pharmacol Sin. 2012. PMID: 22659625 Free PMC article.
-
Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis.Blood. 2010 Dec 2;116(23):5037-44. doi: 10.1182/blood-2010-06-293126. Epub 2010 Aug 24. Blood. 2010. PMID: 20736455 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous